Eginilla 30 mg filmomhulde tabletten

Land: Nederland

Taal: Nederlands

Bron: CBG-MEB (College ter Beoordeling van Geneesmiddelen)

Werkstoffen:

ULIPRISTALACETAAT

Beschikbaar vanaf:

Egis Pharmaceuticals Plc Kereszturi ut 30-38 1106 BOEDAPEST (HONGARIJE)

ATC-code:

G03AD02

INN (Algemene Internationale Benaming):

ULIPRISTALACETAAT

farmaceutische vorm:

Filmomhulde tablet

Samenstelling:

HYPROLOSE (E 463) ; HYPROMELLOSE (E 464) ; LACTOSE 1-WATER ; MAGNESIUMSTEARAAT (E 470b) ; NATRIUMZETMEELGLYCOLAAT ; STEARINEZUUR (E 570) ; TALK (E 553 B) ; TITAANDIOXIDE (E 171) ; ZETMEEL, GEPREGELATINEERD

Toedieningsweg:

Oraal gebruik

Therapeutisch gebied:

Ulipristal

Autorisatie datum:

2019-03-25

Bijsluiter

Seite 1 von 8
PACKAGE LEAFLET: INFORMATION FOR THE USER
EGINILLA 30 MG FILMOMHULDE TABLETTEN
ulipristalacetaat
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
Always take this medicine exactly as described in this leaflet or as
your pharmacist, doctor or other
healthcare professional has told you.
-
Keep this leaflet. You may need to read it again.
-
Ask your pharmacist if you need more information or advice.
-
If you get any side effects, talk to your pharmacist, doctor, or other
healthcare professional.
This includes any possible side effects not listed in this leaflet.
See section 4.
WHAT IS IN THIS LEAFLET:
1.
What Eginilla
is and what it is used for
2.
What you need to know before you use Eginilla
3.
How to use Eginilla
4.
Possible side effects
5.
How to store Eginilla
6.
Contents of the pack and other information
- Useful information about contraception
1. WHAT EGINILLA IS AND WHAT IT IS USED FOR
Eginilla is an emergency contraceptive
Eginilla is a contraceptive intended to prevent pregnancy after
unprotected sex or if your
contraceptive method has failed. For example:
•
if you had sex without protection;
•
if your or your partner’s condom tore, slipped or came off, or if
you forgot to use one;
•
if you did not take your contraceptive pill as recommended.
You should take the tablet as soon as possible after sex, and within a
maximum of 5 days (120
hours).
This is because the sperm can survive up to 5 days in your body after
intercourse.
This medicine is suitable for any woman of childbearing age, including
adolescents.
You can take this tablet at any time in the menstrual cycle.
Eginilla does not work if you are already pregnant.
If your menstrual period is late, there is a possibility
that you may be pregnant. When your period is
late or when you have symptoms of pregnancy (heavy breasts, morning
sickness) you should consult
a doctor or other healthcare professional before taking the tablet.
If you have unprotected sex after

Productkenmerken

Seite 1 von 10
SAMENVATTING VAN DE PRODUCTKENMERKEN
1. NAME OF THE MEDICINAL PRODUCT
Eginilla 30 mg filmomhulde tabletten
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 30 mg ulipristal acetate.
Excipients with known effect:
Each tablet contains 240.0 mg of lactose (as monohydrate) and 1.35 mg
sodium.
For the full list of excipients, see section 6.1
3. PHARMACEUTICAL FORM
Film-coated tablet
White, round, biconvex, film-coated tablet of 9.0 – 9.2 mm diameter
embossed with
_“U30” _
on one
side.
4. CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Emergency contraception within 120 hours (5 days) of unprotected
sexual intercourse or
contraceptive failure.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology
The treatment consists of one tablet to be taken orally as soon as
possible, but no later than 120 hours
(5 days) after unprotected intercourse or contraceptive failure.
This tablet can be taken at any time during the menstrual cycle.
If vomiting occurs within 3 hours of the tablet intake, another tablet
should be taken.
If a woman’s menstrual period is late or in case of symptoms of
pregnancy, pregnancy should be
excluded before the tablet is administered.
Special populations
_Renal impairment _
No dose adjustment is necessary.
_ _
_Hepatic impairment _
In the absence of specific studies, no alternate dose recommendations
for Eginilla can be made.
_ _
_Severe hepatic impairment _
In the absence of specific studies, Eginilla is not recommended.
_ _
_Paediatric population _
Seite 2 von 10
There is no relevant use of ulipristal acetate for children of
prepubertal age in the indication
emergency contraception_. _
Adolescents: ulipristal acetate is suitable for any woman of child
bearing age, including adolescents.
No differences in safety or efficacy have been shown compared to adult
women aged 18 and older
(see section 5.1).
Method of administration
Oral use.
The tablet can be taken with or without food.
4.3 CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipient